Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-04-16 | Amylyx Pharmaceuticals, Inc. | FRATES JAMES M
(Chief Financial Officer) |
A | Common Stock | A | 91180 | $0.00 - $0.00 | $0 |
| 2024-04-16 | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B
(Co-Chief Executive Officer) |
A | Common Stock | A | 179850 | $0.00 - $0.00 | $0 |
| 2024-04-16 | Amylyx Pharmaceuticals, Inc. | Mazzariello Gina
(Chief Legal Officer) |
A | Common Stock | A | 80560 | $0.00 - $0.00 | $0 |
| 2024-04-16 | Amylyx Pharmaceuticals, Inc. | Klee Justin B.
(Co-Chief Executive Officer) |
A | Common Stock | A | 179850 | $0.00 - $0.00 | $0 |
| 2024-04-16 | Amylyx Pharmaceuticals, Inc. | Bedrosian Camille L
(Chief Medical Officer) |
A | Common Stock | A | 96910 | $0.00 - $0.00 | $0 |
| 2024-02-26 | Amylyx Pharmaceuticals, Inc. | FRATES JAMES M
(Chief Financial Officer) |
A | Common Stock | A | 40000 | $0.00 - $0.00 | $0 |
| 2024-02-26 | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B
(Co-Chief Executive Officer) |
A | Common Stock | A | 126667 | $0.00 - $0.00 | $0 |
| 2024-02-26 | Amylyx Pharmaceuticals, Inc. | Klee Justin B.
(Co-Chief Executive Officer) |
A | Common Stock | A | 126667 | $0.00 - $0.00 | $0 |
| 2024-02-26 | Amylyx Pharmaceuticals, Inc. | Mazzariello Gina
(Chief Legal Officer) |
A | Common Stock | A | 36667 | $0.00 - $0.00 | $0 |
| 2024-02-23 | Amylyx Pharmaceuticals, Inc. | Mazzariello Gina
(Chief Legal Officer) |
S | Common Stock | D | 2838 | $18.76 - $18.76 | $53,230 |
| 2024-01-25 | Amylyx Pharmaceuticals, Inc. | MILNE GEORGE M JR
(Director) |
G | Common Stock | D | 9100 | $0.00 - $0.00 | $0 |
| 2024-01-09 | Amylyx Pharmaceuticals, Inc. | Klee Justin B.
(Co-Chief Executive Officer) |
S | Common Stock | D | 5841 | $16.33 - $16.33 | $95,372 |
| 2024-01-09 | Amylyx Pharmaceuticals, Inc. | FRATES JAMES M
(Chief Financial Officer) |
S | Common Stock | D | 2716 | $16.33 - $16.33 | $44,347 |
| 2024-01-09 | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B
(Co-Chief Executive Officer) |
S | Common Stock | D | 5841 | $16.33 - $16.33 | $95,372 |
| 2024-01-09 | Amylyx Pharmaceuticals, Inc. | Yeramian Patrick D
(Chief Medical Officer) |
S | Common Stock | D | 2812 | $16.33 - $16.33 | $45,914 |
| 2023-12-15 | Amylyx Pharmaceuticals, Inc. | Firestone Karen
(Director) |
P | Common Stock | A | 4000 | $14.97 - $14.97 | $59,880 |
| 2023-11-16 | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B
(Co-Chief Executive Officer) |
M | Common Stock | A | 63694 | $1.57 - $1.57 | $99,999 |
| 2023-10-31 | Amylyx Pharmaceuticals, Inc. | FRATES JAMES M
(Chief Financial Officer) |
G | Common Stock | A | 11072 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |